Literature DB >> 8538619

Mechanisms and pathogenesis of thyroid cancer in animals and man.

E D Williams1.   

Abstract

The transformation of the normal fully differentiated thyroid follicular cell to the rapidly growing undifferentiated anaplastic thyroid carcinoma cell involves a number of stages which have been defined morphologically and are now being related to various growth pathways and to molecular biological defects. The two main factors involved in this transformation are growth stimulation and mutagenesis. Growth stimulation alone, through elevated TSH, can lead to the development of thyroid tumours, usually benign, and retaining TSH dependency in some cases. Mutagens alone, if growth is suppressed, do not produce tumours, the combination of mutagens and increased growth is a potent carcinogenic regime. Non-genotoxic carcinogenesis in the thyroid involves growth, without mutagenesis the agent often causes this through affecting one component of thyroid hormone synthesis or metabolism, leading to a fall in thyroid hormone levels and a rise in TSH. Growth stimulation increases the rate of cell division, and therefore increases the chance of a mutation. Continued growth increases the change of subsequent events, in particular loss of heterozygosity in a tumour suppressor gene. The main oncogenes involved in human thyroid carcinogens are ras in the follicular tumour pathway, and ret in the papillary carcinoma pathway. p53 is involved in the progression of either papillary or follicular adenoma to an undifferentiated carcinoma. In experimental thyroid carcinogenesis, ras is again involved, with a link between the mutagenic agent used and the type of ras gene showing mutation. Analysis of the involvement of different growth factors and oncogenes in thyroid carcinogenesis suggests that genes related to the two receptors concerned with normal TSH stimulated growth, TSH receptor and the IGF1 receptor may be involved in the progression of thyroid tumours of follicular pathology. Several tyrosine kinase receptors with unknown ligands or of uncertain physiological function are linked to papillary carcinoma. The recent large increase in papillary carcinoma of the thyroid in children exposed to fallout from the Chernobyl nuclear accident underlines the importance of understanding the pathobiology of thyroid neoplasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8538619     DOI: 10.1016/0027-5107(95)00138-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

1.  Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.

Authors:  Alice J Sigurdson; Charles E Land; Parveen Bhatti; Marbin Pineda; Alina Brenner; Zhanat Carr; Boris I Gusev; Zhaxibay Zhumadilov; Steven L Simon; Andre Bouville; Joni L Rutter; Elaine Ron; Jeffery P Struewing
Journal:  Radiat Res       Date:  2009-01       Impact factor: 2.841

2.  New Evidence on the Association between Prediagnostic Thyroid-Stimulating Hormone Levels and Thyroid Cancer Risk.

Authors:  Cari M Kitahara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-08       Impact factor: 4.254

Review 3.  Cigarette Smoking and Estrogen-Related Cancer.

Authors:  John A Baron; Hazel B Nichols; Chelsea Anderson; Stephen Safe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05-14       Impact factor: 4.254

4.  Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas.

Authors:  Demet Corapcioglu; Serpil D Sak; Tuncay Delibasi; Vedia Tonyukuk; Nuri Kamel; Ali R Uysal; Savas Kocak; Semih Aydintug; Gurbuz Erdogan
Journal:  J Transl Med       Date:  2006-07-05       Impact factor: 5.531

5.  Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours.

Authors:  B Suchy; V Waldmann; S Klugbauer; H M Rabes
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

6.  Risk assessment of thyroid follicular cell tumors.

Authors:  R N Hill; T M Crisp; P M Hurley; S L Rosenthal; D V Singh
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.